Latest Reports

Market Scope’s “2024 Dry Eye Products Market Report” analyzes the current marketplace and forecasts market performance through 2029. The report examines dry eye syndrome’s etiology, diagnosis, and treatment and provides in-depth coverage on the prevalence of dry eye, prescription therapeutics, over-the-counter lubricants, thermal expression, IPL, punctum plugs, and additional dry eye procedures and products.  

Product demand is forecast in units and dollars, and market shares are analyzed by product category. Twenty-five market competitors are profiled, with discussion of their products, strategic market position, background, and outlook. 

In 2024, Market Scope conducted an online survey of US ophthalmologists focused on diagnostic equipment to better understand industry dynamics, gain important insights into leading trends, and explore surgeons’ opinions on current and future technologies. Sponsors were given the opportunity to review survey questions and add additional questions. Email invitations were sent to US ophthalmologists and optometrists who had been individually confirmed and verified on market-scope.com to participate in the survey. Email invitations were sent on Nov. 1, 2024. There were 160 total complete, unique responses in the US.

The “2024 Fundus Imaging Market Report” is a specialized supplement, expanding on the fundus imaging section of Market Scope’s comprehensive, global “2024 Ophthalmic Diagnostic Equipment Market Report.”

The report provides background information about fundus imaging devices and divides estimates into five categories: fundus screeners, diagnostic fundus imaging, advanced fundus imaging, combination systems, and hand-held systems. Estimates include unit sales, installed equipment base, average prices, and information about the manufacturers that participate in the market.

Market Scope’s "2024 Retinal Disease Model" offers extensive country-level prevalence data and five-year forecasts for retinal diseases and conditions by age group for all countries with a population over a million.

This proprietary model takes into consideration the latest clinical research and demographic projections on a global scale and can be customized by geography and disease category to meet clients’ diverse needs. Disease models can be used to evaluate target markets for clinical-stage and commercial-stage products and gain insights into the volume and demographics of diseased populations.

The “2024 Premium Cataract Surgery Market Report” is designed to provide insights into the most important premium cataract surgery (PCS) markets in the world. We’ve selected and profiled 13 countries that collectively account for 84 percent of global PCS manufacturer revenue and provided a deep dive into each of these markets. Ranked by 2024 PCS manufacturer revenue, they are: the United States, China, Japan, France, Germany, Brazil, Canada, India, Spain, South Korea, Australia, the UK, and Italy.  

For each of these countries, the report focuses on specific characteristics considered vital to the understanding of the opportunities for companies planning to market premium cataract surgery devices or looking to assess the value of each market. 

The “2024 Single-Use Ophthalmic Surgical Products Market Report” examines global and regional markets for single-use ophthalmic surgical products. It includes analysis of current markets, identification of important trends, and discussion of key factors for future success.  The report reviews cataract surgery, the dominant procedure in this market, as well as cataract surgery providers worldwide.  

Market segments profiled include viscoelastics, knives, disposable instruments, balanced salt solutions, procedure packs, drapes, sutures, fluid management devices, eye shields, ocular dyes, capsular tension rings, and cautery pencils. 

Additionally, 25 companies are profiled, with discussion of their products, strategic market position, background, and outlook. 

The “2024 United States Cataract Atlas” provides a geographic analysis of the conventional and premium cataract surgery opportunity in 85 US metropolitan areas. Market Scope’s proprietary MedOp Index™ Analysis examines market potential and provides a benchmark against other metros. The atlas offers strategic insights into the top potential markets in the US, which companies often use throughout the development and commercialization processes to identify ideal clinical trial locations, develop launch strategies, define sales territories, allocate resources, and optimize sales and marketing initiatives.

The “2024 United States Refractive Atlas” provides a geographic analysis of the US refractive market in 85 metropolitan areas. Market Scope’s MedOp Index™ Analysis is used to identify the potential for refractive surgery and considers many factors for each geography, including:  population age distribution, refractive error, income/buying power, overall health, education level, and location of refractive surgeons and LVC centers. High-opportunity populations and benchmarking comparisons are provided for each metropolitan area. Additionally, the atlas provides a comprehensive directory of all US practices offering refractive surgery. Market Scope also offers customization of atlas data to align with sales territories or specific geographic areas.

The “2023 United States Retina Atlas” provides a geographic analysis of retinal treatment opportunity and key demographic metrics in 85 US metropolitan areas. Market Scope’s proprietary MedOp Index™ Analysis examines market potential and provides a benchmark against other metros. The Retina Atlas offers strategic insights into the top potential markets in the US by providing:

• Demographic information of selected metropolitan populations
• Profiles of selected metropolitan areas and applicable retinal treatment opportunity
• Current estimates for retinal surgery volume by metropolitan area
• Current estimates for retina surgeons by metropolitan area
• Comprehensive directory of US ophthalmic practices performing retinal IVTs and vitrectomies

The “2023 US and Western Europe Cataract Pharmaceuticals Market Report” offers an in-depth examination of the current cataract pharmaceuticals market in the United States and Western Europe and forecasts market performance over the next five years. The report analyzes the current market and forecasts units, average sales price, and revenue through 2028 by product category. It analyzes products currently on the market and examines the development pipeline, discusses the popularity of intracameral injections and fixed combination eye drops, and analyzes the roles of brand name medications, generics, and compounded formulations.